Related Experiment Video
Updated: Sep 16, 2026

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
[Therapy-refractory pelvic vein thrombosis in pregnancy as a sequela of protein S deficiency]
1Univ.-Klinik f. Chirurgie Graz.
Insights
Protein S deficiency can cause dangerous blood clots during pregnancy. This case highlights recurrent thrombosis in a pregnant woman, suggesting an inherited deficiency as the cause.
Area of Science:
- Hematology
- Genetics
Background:
- Protein S (PS) is a crucial cofactor for activated Protein C, mediating anticoagulation.
- PS deficiency, whether inherited or acquired, is linked to recurrent thromboembolic events.
- Physiological PS levels decrease during pregnancy, puerperium, and oral contraceptive use.
Observation:
- A 26-year-old pregnant woman (39 weeks gestation) presented with descending iliofemoral venous thrombosis.
- Initial venous thrombectomy with an arteriovenous fistula was followed by recurrent thrombosis postpartum.
- Repeat thrombectomy and lysis therapy failed to resolve subsequent recurrent thromboses.
Findings:
- Coagulation analysis revealed markedly reduced functional Protein S activity (34%), the sole pathological finding.
- The patient's mother has a 20-year history of recurrent thromboembolic complications managed with coumarin therapy.
- These factors strongly suggest an underlying inherited Protein S deficiency in the patient.
Implications:
- This case underscores the critical role of Protein S in preventing thrombosis, especially during pregnancy.
- Identifying inherited Protein S deficiency is vital for managing recurrent thromboembolic events.
- Early diagnosis and appropriate anticoagulation strategies are essential for patients with PS deficiency.
Abstract:
Protein S (PS) serves as a cofactor for activated Protein C, which has anticoagulative activity. PS deficiency (inherited or acquired) leads to spontaneous, recurrent thromboembolic complications in adulthood. PS level is significantly reduced during pregnancy and puerperium and during use of oral contraceptives. We report on our experience with a 26 year old pregnant woman, who developed a descending iliofemoral venous thrombosis in the 39th week of gestation. She underwent venous thrombectomy with a temporary arteriovenous fistula. Recurrent thrombosis occurred a few days after parturition. Redothrombectomy was performed successfully, but 2nd recurrent thrombosis occurred 10 days later. Further, lysis therapy did not reopen the venous system. Functional PS activity of 34% (IL-Instrumentation Laboratory Protein S-test, normal range 60-140%) was markedly reduced, which was the only pathological finding of coagulation analysis. For 20 years, the patient's mother has been undergoing coumarin therapy because of recurrent thromboembolic complications. We can therefore assume an inherited PS deficiency in the young mother.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Inhibitors of Viral Protein Synthesis

